Roche Holding | ROG - Selling And Administration Expenses

Stock Price
322.00
Daily Change
-2.90 -0.89%
Monthly
3.21%
Yearly
22.95%
Q2 Forecast
315.69

Roche Holding reported CHF7.28B in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
AbbVie USD 3.89B 325M Dec/2025
Alcon AG USD 901M 36M Dec/2025
Amgen USD 1.94B 237M Dec/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
Bayer EUR 4.05B 647M Dec/2025
Biogen USD 545.2M 38.6M Sep/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Eli Lilly USD 3.13B 391.3M Dec/2025
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 785M 79.56M Dec/2025
Galapagos EUR 44.42M 9.87M Dec/2025
Genmab DKK 208M 60M Dec/2025
Gilead Sciences USD 1.78B 425M Dec/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GRIFOLS EUR 275.3M 9.7M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Merck EUR 1.6B 136M Dec/2025
Merck USD 2.85B 215M Dec/2025
Novartis USD 3.44B 128M Dec/2025
Orion EUR 91.9M 18.8M Mar/2026
Pfizer USD 4.08B 894M Dec/2025
Philips EUR 1.31B 127M Dec/2025
Recordati EUR 171.38M 15.6M Sep/2025
Regeneron Pharmaceuticals USD 775M 117.2M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.33B 419M Mar/2026
UCB EUR 1.47B 193M Dec/2025